Automates echocardiography measurements and reporting for clinicians using FDA-cleared AI.
Product memo
ICardio.ai targets ultrasound teams and clinicians, automating critical echocardiography measurements and aortic stenosis detection. Its FDA-cleared AI tools shorten report generation and integrate into existing PACS and hardware workflows via API. The company partners with ultrasound providers globally, embedding AI-driven insights directly into clinical practice.
For who
Ultrasound teams and clinicians
Solves what
Automates echocardiography measurements and reporting with AI.
- Automated echo measurements
- Aortic stenosis detection
- AI-assisted reporting
In their own words
Ultrasound,
We are on a mission to automate Ultrasound with artificial intelligence. We partner with Ultrasound companies to deliver our technology to clinicians around the globe.
Operator context
Operating setup
Founded
May 2026
HQ
United States
Platform
API
Audience
Developers
Social footprint
Tech stack
Market demand
Icardio keyword demand
5 keywords
Market demand is Starter-tier market intelligence.
Derived from this product’s latest SimilarWeb keyword mix — directional demand, not proof.
Builder Strategy
- Strategy Type
- Niche Specialist
- Stage
- Vc Growth
- Effort
- Small Team
About Icardio Expand
ICardio.ai provides AI-powered automation for echocardiography measurements and reporting, serving ultrasound teams and clinicians. It offers automated echo measurements, including aortic stenosis detection, and generates broad echo reports.
The platform integrates via API into existing PACS and hardware workflows, enhancing efficiency in clinical settings. With FDA-cleared AI tools, iCardio.ai focuses on B2B partnerships with ultrasound companies to embed its technology, aiming to deliver AI-driven insights directly to clinicians globally.